Form 4: CervoMed Inc. Director's Spouse Granted Stock Options

Sylvie Gregoire, spouse of CervoMed Inc.'s CEO John Alam, reports acquisition of stock options.

Summary

• Sylvie Gregoire, a director and 10% owner of CervoMed Inc., filed a Form 4.
• The report details the acquisition of stock options by her spouse, John Alam, who is the Chief Executive Officer of CervoMed Inc.
• On February 4, 2025, John Alam was granted options to purchase 60,000 shares of CervoMed Inc. common stock at an exercise price of $2.30.
• The options vest in 36 equal monthly installments starting February 28, 2025, and expire on February 4, 2035.
• Sylvie Gregoire disclaims beneficial ownership of these securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to stock option grants, which is generally neutral in sentiment.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Related Party Transactions

• The stock option grant to John Alam, the CEO, is a related party transaction as his spouse, Sylvie Gregoire, is a director and 10% owner of the company.

Stakeholder Impact

• The stock option grant could incentivize the CEO to improve company performance, potentially benefiting shareholders.
• The dilution effect of the options, if exercised, could have a minor negative impact on existing shareholders.

Key Dates

Keywords

Form 4, Stock Options, Beneficial Ownership, CervoMed Inc., CRVO, Director, John Alam, Sylvie Gregoire